Methamphetamine	B:C0025611
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	O
)	O
and	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	O
effects	I:C0596402
in	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
.	O

Methamphetamine	O
,	O
3,4-	B:C0115471
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	O
)	O
and	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	O
effects	I:C0596402
in	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
.	O

Methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	B:C0115471
)	O
and	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	O
effects	I:C0596402
in	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
.	O

Methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	O
)	O
and	O
3,4-	B:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	O
effects	I:C0596402
in	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
.	O

Methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	O
)	O
and	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	B:C2974592
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	O
effects	I:C0596402
in	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
.	O

Methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	O
)	O
and	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	B:C0596402
effects	I:C0596402
in	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
.	O

Methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	O
)	O
and	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	O
effects	I:C0596402
in	O
bovine	B:C0007452
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
.	O

Methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	O
)	O
and	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	O
effects	I:C0596402
in	O
bovine	O
brain	B:C0006104
microvessel	O
endothelial	O
cells	I:C0225336
.	O

Methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	O
)	O
and	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	O
effects	I:C0596402
in	O
bovine	O
brain	O
microvessel	B:C2350570
endothelial	O
cells	I:C0225336
.	O

Methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
(	O
3,4-methylenedioxymethamphetamine	O
)	O
and	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
induce	O
differential	O
cytotoxic	O
effects	I:C0596402
in	O
bovine	O
brain	O
microvessel	O
endothelial	B:C0225336
cells	I:C0225336
.	O

Designer	B:C0011684
drugs	I:C0011684
such	O
as	O
synthetic	O
psychostimulants	I:C0304403
are	O
indicative	O
of	O
a	O
worldwide	O
problem	O
of	O
drug	O
abuse	I:C0013146
and	O
addiction	O
.	O

Designer	O
drugs	I:C0011684
such	O
as	O
synthetic	B:C0304403
psychostimulants	I:C0304403
are	O
indicative	O
of	O
a	O
worldwide	O
problem	O
of	O
drug	O
abuse	I:C0013146
and	O
addiction	O
.	O

Designer	O
drugs	I:C0011684
such	O
as	O
synthetic	O
psychostimulants	I:C0304403
are	O
indicative	O
of	O
a	O
worldwide	O
problem	B:C0033213
of	O
drug	O
abuse	I:C0013146
and	O
addiction	O
.	O

Designer	O
drugs	I:C0011684
such	O
as	O
synthetic	O
psychostimulants	I:C0304403
are	O
indicative	O
of	O
a	O
worldwide	O
problem	O
of	O
drug	B:C0013146
abuse	I:C0013146
and	O
addiction	O
.	O

Designer	O
drugs	I:C0011684
such	O
as	O
synthetic	O
psychostimulants	I:C0304403
are	O
indicative	O
of	O
a	O
worldwide	O
problem	O
of	O
drug	O
abuse	I:C0013146
and	O
addiction	B:C1510472
.	O

In	O
addition	O
to	O
methamphetamine	B:C0025611
(	O
methamphetamine	O
)	O
,	O
these	O
drugs	O
include	O
3,4	O
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	O
preparations	O
of	O
synthetic	O
cathinones	I:C0054876
including	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	O
salts	I:C0771243
.	O
"	O

In	O
addition	O
to	O
methamphetamine	O
(	O
methamphetamine	B:C0025611
)	O
,	O
these	O
drugs	O
include	O
3,4	O
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	O
preparations	O
of	O
synthetic	O
cathinones	I:C0054876
including	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	O
salts	I:C0771243
.	O
"	O

In	O
addition	O
to	O
methamphetamine	O
(	O
methamphetamine	O
)	O
,	O
these	O
drugs	B:C0011684
include	O
3,4	O
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	O
preparations	O
of	O
synthetic	O
cathinones	I:C0054876
including	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	O
salts	I:C0771243
.	O
"	O

In	O
addition	O
to	O
methamphetamine	O
(	O
methamphetamine	O
)	O
,	O
these	O
drugs	O
include	O
3,4	B:C0115471
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	O
preparations	O
of	O
synthetic	O
cathinones	I:C0054876
including	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	O
salts	I:C0771243
.	O
"	O

In	O
addition	O
to	O
methamphetamine	O
(	O
methamphetamine	O
)	O
,	O
these	O
drugs	O
include	O
3,4	O
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	B:C0115471
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	O
preparations	O
of	O
synthetic	O
cathinones	I:C0054876
including	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	O
salts	I:C0771243
.	O
"	O

In	O
addition	O
to	O
methamphetamine	O
(	O
methamphetamine	O
)	O
,	O
these	O
drugs	O
include	O
3,4	O
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	B:C0680536
preparations	O
of	O
synthetic	O
cathinones	I:C0054876
including	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	O
salts	I:C0771243
.	O
"	O

In	O
addition	O
to	O
methamphetamine	O
(	O
methamphetamine	O
)	O
,	O
these	O
drugs	O
include	O
3,4	O
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	O
preparations	O
of	O
synthetic	B:C0054876
cathinones	I:C0054876
including	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	O
salts	I:C0771243
.	O
"	O

In	O
addition	O
to	O
methamphetamine	O
(	O
methamphetamine	O
)	O
,	O
these	O
drugs	O
include	O
3,4	O
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	O
preparations	O
of	O
synthetic	O
cathinones	I:C0054876
including	O
3,4	B:C2974592
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	O
salts	I:C0771243
.	O
"	O

In	O
addition	O
to	O
methamphetamine	O
(	O
methamphetamine	O
)	O
,	O
these	O
drugs	O
include	O
3,4	O
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	O
preparations	O
of	O
synthetic	O
cathinones	I:C0054876
including	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	B:C2974592
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	O
salts	I:C0771243
.	O
"	O

In	O
addition	O
to	O
methamphetamine	O
(	O
methamphetamine	O
)	O
,	O
these	O
drugs	O
include	O
3,4	O
-	I:C0115471
methylenedioxy	I:C0115471
-	I:C0115471
methamphetamine	I:C0115471
(	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
)	O
and	O
commercial	O
preparations	O
of	O
synthetic	O
cathinones	I:C0054876
including	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
(	O
3,4-	O
methylenedioxypyrovalerone	I:C2974592
)	O
,	O
typically	O
referred	O
to	O
as	O
"	O
bath	B:C0771243
salts	I:C0771243
.	O
"	O

These	O
psychostimulants	B:C0304403
exert	O
neurotoxic	O
effects	I:C0235032
by	O
altering	O
monoamine	O
systems	O
in	O
the	O
brain	O
.	O

These	O
psychostimulants	O
exert	O
neurotoxic	B:C0235032
effects	I:C0235032
by	O
altering	O
monoamine	O
systems	O
in	O
the	O
brain	O
.	O

These	O
psychostimulants	O
exert	O
neurotoxic	O
effects	I:C0235032
by	O
altering	O
monoamine	O
systems	O
in	O
the	O
brain	B:C0006104
.	O

Additionally	O
,	O
methamphetamine	B:C0025611
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
adversely	O
affect	I:C0879626
the	O
integrity	O
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
(	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
)	O
:	O
there	O
are	O
no	O
current	O
reports	O
on	O
the	O
effects	O
of	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

Additionally	O
,	O
methamphetamine	O
and	O
3,4	B:C0115471
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
adversely	O
affect	I:C0879626
the	O
integrity	O
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
(	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
)	O
:	O
there	O
are	O
no	O
current	O
reports	O
on	O
the	O
effects	O
of	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

Additionally	O
,	O
methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
adversely	B:C0879626
affect	I:C0879626
the	O
integrity	O
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
(	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
)	O
:	O
there	O
are	O
no	O
current	O
reports	O
on	O
the	O
effects	O
of	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

Additionally	O
,	O
methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
adversely	O
affect	I:C0879626
the	O
integrity	O
of	O
the	O
blood	B:C0005854
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
(	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
)	O
:	O
there	O
are	O
no	O
current	O
reports	O
on	O
the	O
effects	O
of	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

Additionally	O
,	O
methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
adversely	O
affect	I:C0879626
the	O
integrity	O
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
(	O
blood	B:C0005854
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
)	O
:	O
there	O
are	O
no	O
current	O
reports	O
on	O
the	O
effects	O
of	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

Additionally	O
,	O
methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
adversely	O
affect	I:C0879626
the	O
integrity	O
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
(	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
)	O
:	O
there	O
are	O
no	O
current	O
reports	B:C0684224
on	O
the	O
effects	O
of	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

Additionally	O
,	O
methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
adversely	O
affect	I:C0879626
the	O
integrity	O
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
(	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
)	O
:	O
there	O
are	O
no	O
current	O
reports	O
on	O
the	O
effects	O
of	O
3,4	B:C2974592
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

Additionally	O
,	O
methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
adversely	O
affect	I:C0879626
the	O
integrity	O
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
(	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
)	O
:	O
there	O
are	O
no	O
current	O
reports	O
on	O
the	O
effects	O
of	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
the	O
blood	B:C0005854
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	B:C2603343
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	B:C0025611
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	B:C0115471
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	B:C2974592
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	B:C0007452
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	B:C0006104
microvessel	O
endothelial	O
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	O
microvessel	B:C2350570
endothelial	O
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	O
microvessel	O
endothelial	B:C0225336
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
(	O
bovine	B:C0225336
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	B:C1515654
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
methamphetamine	O
,	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
on	O
bovine	O
brain	O
microvessel	O
endothelial	O
cells	I:C0225336
(	O
bovine	O
brain	I:C0225336
microvessel	I:C0225336
endothelial	I:C0225336
cells	I:C0225336
)	O
,	O
an	O
accepted	O
in	O
vitro	I:C1515654
model	I:C1515654
of	O
the	O
blood	B:C0005854
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
.	O

Confluent	O
bBMVEC	B:C0225336
monolayers	O
were	O
treated	O
with	O
methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
and	O
3,4-methylenedioxypyrovalerone	O
(	O
0.5	O
mM	O
-2.5	O
mM	O
)	O
for	O
24h	O
.	O

Confluent	O
bBMVEC	O
monolayers	B:C0934502
were	O
treated	O
with	O
methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
and	O
3,4-methylenedioxypyrovalerone	O
(	O
0.5	O
mM	O
-2.5	O
mM	O
)	O
for	O
24h	O
.	O

Confluent	O
bBMVEC	O
monolayers	O
were	O
treated	O
with	O
methamphetamine	B:C0025611
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
and	O
3,4-methylenedioxypyrovalerone	O
(	O
0.5	O
mM	O
-2.5	O
mM	O
)	O
for	O
24h	O
.	O

Confluent	O
bBMVEC	O
monolayers	O
were	O
treated	O
with	O
methamphetamine	O
,	O
3,4-	B:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
3,4-methylenedioxypyrovalerone	O
(	O
0.5	O
mM	O
-2.5	O
mM	O
)	O
for	O
24h	O
.	O

Confluent	O
bBMVEC	O
monolayers	O
were	O
treated	O
with	O
methamphetamine	O
,	O
3,4-	O
methylenedioxymethamphetamine	I:C0115471
and	O
3,4-methylenedioxypyrovalerone	B:C2974592
(	O
0.5	O
mM	O
-2.5	O
mM	O
)	O
for	O
24h	O
.	O

methamphetamine	B:C0025611
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
increased	O
lactate	O
dehydrogenase	I:C0022917
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2.5	O
mM	O
)	O
,	O
whereas	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
cytotoxicity	O
at	O
all	O
concentration	O
s.	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
methamphetamine	O
decreased	O
cellular	O
proliferation	I:C0596290
only	O
at	O
2.5	O
mM	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
exposures	O
starting	O
at	O
1	O
mM	O
.	O

methamphetamine	O
and	O
3,4	B:C0115471
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
increased	O
lactate	O
dehydrogenase	I:C0022917
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2.5	O
mM	O
)	O
,	O
whereas	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
cytotoxicity	O
at	O
all	O
concentration	O
s.	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
methamphetamine	O
decreased	O
cellular	O
proliferation	I:C0596290
only	O
at	O
2.5	O
mM	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
exposures	O
starting	O
at	O
1	O
mM	O
.	O

methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
increased	O
lactate	B:C0022917
dehydrogenase	I:C0022917
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2.5	O
mM	O
)	O
,	O
whereas	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
cytotoxicity	O
at	O
all	O
concentration	O
s.	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
methamphetamine	O
decreased	O
cellular	O
proliferation	I:C0596290
only	O
at	O
2.5	O
mM	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
exposures	O
starting	O
at	O
1	O
mM	O
.	O

methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
increased	O
lactate	O
dehydrogenase	I:C0022917
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2.5	O
mM	O
)	O
,	O
whereas	O
3,4	B:C2974592
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
cytotoxicity	O
at	O
all	O
concentration	O
s.	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
methamphetamine	O
decreased	O
cellular	O
proliferation	I:C0596290
only	O
at	O
2.5	O
mM	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
exposures	O
starting	O
at	O
1	O
mM	O
.	O

methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
increased	O
lactate	O
dehydrogenase	I:C0022917
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2.5	O
mM	O
)	O
,	O
whereas	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
cytotoxicity	B:C0596402
at	O
all	O
concentration	O
s.	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
methamphetamine	O
decreased	O
cellular	O
proliferation	I:C0596290
only	O
at	O
2.5	O
mM	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
exposures	O
starting	O
at	O
1	O
mM	O
.	O

methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
increased	O
lactate	O
dehydrogenase	I:C0022917
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2.5	O
mM	O
)	O
,	O
whereas	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
cytotoxicity	O
at	O
all	O
concentration	O
s.	O
3,4	B:C0115471
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
methamphetamine	O
decreased	O
cellular	O
proliferation	I:C0596290
only	O
at	O
2.5	O
mM	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
exposures	O
starting	O
at	O
1	O
mM	O
.	O

methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
increased	O
lactate	O
dehydrogenase	I:C0022917
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2.5	O
mM	O
)	O
,	O
whereas	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
cytotoxicity	O
at	O
all	O
concentration	O
s.	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
methamphetamine	B:C0025611
decreased	O
cellular	O
proliferation	I:C0596290
only	O
at	O
2.5	O
mM	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
exposures	O
starting	O
at	O
1	O
mM	O
.	O

methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
increased	O
lactate	O
dehydrogenase	I:C0022917
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2.5	O
mM	O
)	O
,	O
whereas	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
cytotoxicity	O
at	O
all	O
concentration	O
s.	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
methamphetamine	O
decreased	O
cellular	B:C0596290
proliferation	I:C0596290
only	O
at	O
2.5	O
mM	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
exposures	O
starting	O
at	O
1	O
mM	O
.	O

methamphetamine	O
and	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
increased	O
lactate	O
dehydrogenase	I:C0022917
release	O
only	O
at	O
the	O
highest	O
concentration	O
(	O
2.5	O
mM	O
)	O
,	O
whereas	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
cytotoxicity	O
at	O
all	O
concentration	O
s.	O
3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
and	O
methamphetamine	O
decreased	O
cellular	O
proliferation	I:C0596290
only	O
at	O
2.5	O
mM	O
,	O
with	O
similar	O
effects	O
observed	O
after	O
3,4	B:C2974592
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
exposures	O
starting	O
at	O
1	O
mM	O
.	O

Only	O
3,4	B:C2974592
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
increased	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
production	O
at	O
all	O
concentrations	O
tested	O
whereas	O
all	O
3	O
drugs	O
increased	O
nitric	O
oxide	I:C0028128
production	O
.	O

Only	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
increased	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
production	O
at	O
all	O
concentrations	O
tested	O
whereas	O
all	O
3	O
drugs	O
increased	O
nitric	O
oxide	I:C0028128
production	O
.	O

Only	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
increased	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
production	O
at	O
all	O
concentrations	O
tested	O
whereas	O
all	O
3	O
drugs	B:C0011684
increased	O
nitric	O
oxide	I:C0028128
production	O
.	O

Only	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
increased	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
production	O
at	O
all	O
concentrations	O
tested	O
whereas	O
all	O
3	O
drugs	O
increased	O
nitric	B:C0028128
oxide	I:C0028128
production	O
.	O

Morphological	B:C0936012
analysis	I:C0936012
revealed	O
different	O
patterns	O
of	O
compound	O
-	O
induced	O
cell	O
damage	O
.	O

Morphological	O
analysis	I:C0936012
revealed	O
different	O
patterns	O
of	O
compound	B:C1706082
-	O
induced	O
cell	O
damage	O
.	O

methamphetamine	B:C0025611
induced	O
vacuole	O
formatio	O
n	O
at	O
1	O
mM	O
and	O
disruption	O
of	O
the	O
monolayer	O
at	O
2.5	O
mM	O
.	O

methamphetamine	O
induced	O
vacuole	B:C0042219
formatio	O
n	O
at	O
1	O
mM	O
and	O
disruption	O
of	O
the	O
monolayer	O
at	O
2.5	O
mM	O
.	O

methamphetamine	O
induced	O
vacuole	O
formatio	O
n	O
at	O
1	O
mM	O
and	O
disruption	O
of	O
the	O
monolayer	B:C0934502
at	O
2.5	O
mM	O
.	O

3,4	B:C0115471
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
induced	O
disruption	O
of	O
the	O
endothelial	O
monolayer	O
from	O
1	O
mM	O
without	O
vacuolization	O
.	O

3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
induced	O
disruption	O
of	O
the	O
endothelial	B:C0225336
monolayer	O
from	O
1	O
mM	O
without	O
vacuolization	O
.	O

3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
induced	O
disruption	O
of	O
the	O
endothelial	O
monolayer	B:C0934502
from	O
1	O
mM	O
without	O
vacuolization	O
.	O

3,4	O
-	I:C0115471
methylenedioxymethamphetamine	I:C0115471
induced	O
disruption	O
of	O
the	O
endothelial	O
monolayer	O
from	O
1	O
mM	O
without	O
vacuolization	B:C0010840
.	O

On	O
the	O
other	O
hand	O
,	O
3,4	B:C2974592
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
monolayer	O
disruption	O
at	O
doses	O
≥	O
0.5	O
mM	O
without	O
vacuole	O
formation	O
;	O
at	O
2.5	O
mM	O
,	O
the	O
few	O
remaining	O
cells	O
lacked	O
endothelial	O
morphology	O
.	O

On	O
the	O
other	O
hand	O
,	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
monolayer	B:C0934502
disruption	O
at	O
doses	O
≥	O
0.5	O
mM	O
without	O
vacuole	O
formation	O
;	O
at	O
2.5	O
mM	O
,	O
the	O
few	O
remaining	O
cells	O
lacked	O
endothelial	O
morphology	O
.	O

On	O
the	O
other	O
hand	O
,	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
monolayer	O
disruption	O
at	O
doses	O
≥	O
0.5	O
mM	O
without	O
vacuole	B:C0042219
formation	O
;	O
at	O
2.5	O
mM	O
,	O
the	O
few	O
remaining	O
cells	O
lacked	O
endothelial	O
morphology	O
.	O

On	O
the	O
other	O
hand	O
,	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
induced	O
monolayer	O
disruption	O
at	O
doses	O
≥	O
0.5	O
mM	O
without	O
vacuole	O
formation	O
;	O
at	O
2.5	O
mM	O
,	O
the	O
few	O
remaining	O
cells	B:C0007634
lacked	O
endothelial	O
morphology	O
.	O

These	O
data	O
suggest	O
that	O
even	O
though	O
these	O
synthetic	B:C0304403
psychostimulants	I:C0304403
alter	O
monoaminergic	O
systems	O
,	O
they	O
each	O
induce	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
toxicity	O
by	O
different	O
mechanisms	O
with	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
being	O
the	O
most	O
toxic	O
.	O

These	O
data	O
suggest	O
that	O
even	O
though	O
these	O
synthetic	O
psychostimulants	I:C0304403
alter	O
monoaminergic	O
systems	O
,	O
they	O
each	O
induce	O
blood	B:C0005854
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
toxicity	O
by	O
different	O
mechanisms	O
with	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
being	O
the	O
most	O
toxic	O
.	O

These	O
data	O
suggest	O
that	O
even	O
though	O
these	O
synthetic	O
psychostimulants	I:C0304403
alter	O
monoaminergic	O
systems	O
,	O
they	O
each	O
induce	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
toxicity	B:C0013221
by	O
different	O
mechanisms	O
with	O
3,4	O
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
being	O
the	O
most	O
toxic	O
.	O

These	O
data	O
suggest	O
that	O
even	O
though	O
these	O
synthetic	O
psychostimulants	I:C0304403
alter	O
monoaminergic	O
systems	O
,	O
they	O
each	O
induce	O
blood	O
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
toxicity	O
by	O
different	O
mechanisms	O
with	O
3,4	B:C2974592
-	I:C2974592
methylenedioxypyrovalerone	I:C2974592
being	O
the	O
most	O
toxic	O
.	O

